Attenuation of NK cells facilitates mammary tumor growth in streptozotocin-induced diabetes in mice
- 1 April 2018
- journal article
- research article
- Published by Bioscientifica in Endocrine-Related Cancer
- Vol. 25 (4) , 493-507
Abstract
Diabetic patients have higher incidence and mortality of cancer. Recent study revealed that hyperglycemia-induced oxidative stress is involved in the acceleration of tumor metastasis. We used model of high-dose streptozotocin-induced diabetes to investigate its effect on tumor growth and modulation of antitumor immune response of 4T1 murine breast cancer in BALB/c mice. Diabetes accelerated tumor appearance, growth and weight, which was associated with decreased NK cells cytotoxicity against 4T1 tumor cellsin vitro. Diabetes reduced frequencies of systemic NKG2D+, perforin+, granzyme+, IFN-γ+and IL-17+NK cells, while increased level of PD-1 expression and production of IL-10 in NK cells. Diabetes decreased percentage of NKG2D+NK cells and increased percentage of PD-1+NK cells also in primary tumor. Diabetes increased accumulation of IL-10+Tregs and TGF-β+myeloid-derived suppressor cells (MDSCs) in spleen and tumor. Diabetic serain vitrosignificantly increased the percentage of KLRG-1+and PD-1+NK cells, decreased the percentage of IFN-γ+NK cells, expression of NKp46 and production of perforin, granzyme, CD107a and IL-17 per NK cell in comparison to glucose-added mouse sera and control sera. Significantly increased percentages of inducible nitric oxide synthase (iNOS) and indoleamine 2,3-dioxygenase (IDO) producing MDSCs and dendritic cells (DC) were found in the spleens of diabetic mice prior to tumor induction. 1-methyl-DL-tryptophan, specific IDO inhibitor, almost completely restored phenotype of NK cells cultivated in diabetic sera. These findings indicate that diabetes promotes breast cancer growth at least in part through increased accumulation of immunosuppressive cells and IDO-mediated attenuation of NK cells.Keywords
This publication has 44 references indexed in Scilit:
- Natural Killer Cell Function, an Important Target for Infection and Tumor Protection, Is Impaired in Type 2 DiabetesPLOS ONE, 2013
- Indoleamine 2,3-Dioxygenase and Dendritic Cell TolerogenicityImmunological Investigations, 2012
- Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppressionSeminars in Cancer Biology, 2012
- Myeloid-derived suppressor cells: mechanisms of action and recent advances in their role in transplant toleranceFrontiers in Immunology, 2012
- Natural Killer Cells From Children With Type 1 Diabetes Have Defects in NKG2D-Dependent Function and SignalingDiabetes, 2011
- Diabetes and CancerDiabetes Care, 2010
- Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor #Hepatology, 2009
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- Myeloid-derived suppressor cells as regulators of the immune systemNature Reviews Immunology, 2009
- Acute hyperglycemia and oxidative stress: Direct cause and effect?Free Radical Biology and Medicine, 2008